Clearmind Medicine
CMND
6 hedge funds and large institutions have $137K invested in Clearmind Medicine in 2023 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
20% more funds holding
Funds holding: 5 → 6 (+1)
19% more capital invested
Capital invested by funds: $115K → $137K (+$21.7K)
0% more ownership
Funds ownership: 0% → 0% (+0%)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Walleye Capital
New York
|
+$147K |
| 2 |
WAM
Warberg Asset Management
Winnetka,
Illinois
|
+$82.4K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$18.3K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$4.58K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$9.16K |
| 2 |
HF
HRT Financial
New York
|
-$8K |
| 3 |
TSS
Two Sigma Securities
New York
|
-$5.87K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1.94K |
| 5 |
ODG
O'Dell Group
Cincinnati,
Ohio
|
-$9 |
CMND Hedge Fund Activity: Q3 2023 in Review
6 institutional investors reported a position in Clearmind Medicine (CMND) for Q3 2023, worth a combined $137K — up 19% from $115K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new CMND positions and 2 closed out — a net gain of 1 holder — while 1 added to existing stakes and 1 trimmed.
The largest buyer was Walleye Capital, opening a new position worth an estimated $147K. The largest seller was Citadel Advisors, cutting an estimated $9.16K.
- 6 institutional investors held Clearmind Medicine (CMND) as of Q3 2023, up from 5 in Q2 2023.
- Funds reported $137K of Clearmind Medicine stock for Q3 2023, up 19% quarter-over-quarter.
- 3 funds opened new Clearmind Medicine positions in Q3 2023 and 2 closed out, a net change of +1 holder.
- The largest Clearmind Medicine buyer in Q3 2023 was Walleye Capital, an estimated $147K added.
- The largest Clearmind Medicine seller in Q3 2023 was Citadel Advisors, an estimated $9.16K sold.
Based on aggregated 13F filings for Q3 2023.